Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients

Exclusion Criteria

• •Patients \<18 years of age;
• •Documented Pseudomonas infection or colonization in the last 30 days;
• •Immunocompromised patients
• •Hypersensitivity to the study drug and/or to prior therapy with monoclonal antibodies;
• •Patient who has taken other investigational drugs or prohibited therapy for this study within 1 month or 5 half-lives, whichever is longer;
• •Patient or LAR who withdraws consent during the screening (starting from signed informed consent form);
• •Acute liver injury related criteria at the time of study entry:
• •Pregnant or breast-feeding women
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.